Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity

J Immunol. 2002 Apr 1;168(7):3303-8. doi: 10.4049/jimmunol.168.7.3303.

Abstract

The epidermal Langerhans cells (LC), a member of the dendritic cell family, and the LC-derived cytokine IL-12 play a pivotal role in the initiation of contact hypersensitivity (CHS), a Th1 immune response in the skin. Because IL-18, another LC-derived cytokine, shares functional and biological properties with IL-12, we examined a potential role for IL-18 in CHS initiation. Our studies demonstrated that during the induction phase of murine CHS, IL-18 mRNA was significantly up-regulated in the skin-draining lymph nodes (LN). Migratory hapten-modified LC in LN expressed high levels of IL-18 mRNA and secreted functional IL-18 protein. LN cells produced significant amounts of IFN-gamma following in vitro IL-12 stimulation, which could be partially blocked by anti-IL-18 Ab, suggesting a synergistic role for endogenous IL-18 in IFN-gamma production by LN cells. Because mature IL-18 requires cleavage of immature precursors by caspase-1, we further examined IL-12-induced IFN-gamma production in caspase-1(-/-) LN cells. An impaired IFN-gamma production was seen in caspase-1(-/-) LN cells, which could be restored by addition of exogenous IL-18, supporting a role for caspase-1-cleaved, mature IL-18 in IFN-gamma production. Finally, in vivo studies showed that CHS responses were significantly inhibited in mice treated with neutralizing IL-18 Ab as well as in caspase-1(-/-) mice deficient in mature IL-18, indicating functional relevance for IL-18 in CHS. Taken together, our studies demonstrate that LC-derived IL-18 significantly contributes to CHS initiation.

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Caspase 1 / deficiency
  • Caspase 1 / genetics
  • Cell Line
  • Cell Movement / immunology
  • Dermatitis, Contact / enzymology
  • Dermatitis, Contact / genetics
  • Dermatitis, Contact / immunology*
  • Dermatitis, Contact / prevention & control
  • Haptens / administration & dosage
  • Haptens / immunology
  • Immune Sera / administration & dosage
  • Immunization
  • Injections, Intraperitoneal
  • Interferon-gamma / antagonists & inhibitors
  • Interferon-gamma / biosynthesis
  • Interleukin-12 / antagonists & inhibitors
  • Interleukin-12 / pharmacology
  • Interleukin-18 / immunology
  • Interleukin-18 / metabolism
  • Interleukin-18 / pharmacology
  • Interleukin-18 / physiology*
  • Langerhans Cells / immunology*
  • Langerhans Cells / metabolism*
  • Lymph Nodes / enzymology
  • Lymph Nodes / immunology
  • Lymph Nodes / metabolism
  • Lymph Nodes / pathology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Oxazolone / administration & dosage
  • Oxazolone / immunology
  • RNA, Messenger / biosynthesis
  • Up-Regulation / genetics
  • Up-Regulation / immunology

Substances

  • Haptens
  • Immune Sera
  • Interleukin-18
  • RNA, Messenger
  • Oxazolone
  • Interleukin-12
  • Interferon-gamma
  • Caspase 1